Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
Clinical trial NCT00726687 · UNKNOWN
Trial details
- NCT number
- NCT00726687
- Sponsor
- Alaunos Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2013-06-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.